Will the FDA approve Rocket Pharmaceuticals' Biologics License Application for KRESLADI by March 31?
2
Ṁ100Ṁ1kApr 1
1%
chance
79
1H
6H
1D
1W
1M
ALL
Resolution Rules:
YES: If the FDA grants marketing approval for KRESLADI on or before March 28, 2026.
NO: If the FDA issues another Complete Response Letter (CRL) or the application is withdrawn.
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
22% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
26% chance
Will a novel therapeutic/device which confers a survival benefit for glioblastoma be FDA approved by EOY 2028?
51% chance
Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
84% chance
💊Will INS018_055 be FDA-approved by 2030?
48% chance